Spiroglumide

CAS No. 137795-35-8

Spiroglumide( —— )

Catalog No. M36133 CAS No. 137795-35-8

Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 240 Get Quote
5MG 371 Get Quote
10MG 561 Get Quote
25MG 868 Get Quote
50MG 1178 Get Quote
100MG 1557 Get Quote
500MG 3114 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Spiroglumide
  • Note
    Research use only, not for human use.
  • Brief Description
    Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
  • Description
    Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Cholecystokinin Receptor
  • Recptor
    cholecystokinin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    137795-35-8
  • Formula Weight
    441.35
  • Molecular Formula
    C21H26Cl2N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C([C@H](NC(=O)C1=CC(Cl)=CC(Cl)=C1)CCC(O)=O)(=O)N2CCC3(CC2)CCCC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • SR146131

    SR146131 (SR-146131) a small molecule positive allosteric modulator of the type 1 cholecystokinin receptor (CCK1R) with pEC50 of 10.34.

  • JNJ-26070109

    A novel, potent, selective orally active CCK-2 receptor antagonist with pKi of 8.49 for hCCK2.

  • Itriglumide

    Itriglumide (CR-2945) is a cholecystokinin (CCK)-2 receptor antagonist with antisecretory and antiulcerogenic properties.